Niagen Bioscience Inc. (NAGE)
NASDAQ: NAGEConsumer DefensivePackaged FoodsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
NAGE stock chart
Technical analysisKey statistics
All statistics- Market cap
- $215.22M
- P/E (TTM)
- 14.32
- Forward P/E
- 27.20
- EPS (TTM)
- $0.19
- Dividend yield
- None
- 52-week range
- 2.61 – 7.95
- Day range
- 2.65 – 2.76
- Volume / Avg
- 361.06K / 589.35K
- Beta
- —
- Shares outstanding
- 79.13M
- Next earnings
- Nov 3, 2026
52-week range
NAGE stock today
On Oct 7, NAGE ended the session at $2.72, adding $0.03 (1.12%), versus the S&P 500's 0.22% decline. Shares are 65.8% below their 52-week high of $7.95, set on Nov 5, 2025 and 4.2% above the 52-week low of $2.61, near the bottom of the past year's range. NAGE is down 57.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 62.1%.
At 14.3x trailing earnings, Niagen Bioscience trades above the peer-group median of 12.5x. Its forward P/E of 27.2x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year. Niagen Bioscience's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Niagen Bioscience
Company profileNiagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- CEO
- Mr. Robert N. Fried
- Headquarters
- Los Angeles, CA
- Employees
- 117
- Website
- niagenbioscience.com
Analyst forecast
ForecastConsensus (6 analysts)
strong_buy
Avg. price target
$12.08+344.12%
- Strong buy 0
- Buy 6
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $0.00
Niagen Bioscience peers
Consumer Defensive sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BGSB&G Foods Inc. | 2.53 | +3.69% | $205.63M | vs NAGE |
| NATRNature's Sunshine Products Inc. | 12.59 | +0.40% | $221.53M | vs NAGE |
| BRCCBRC Inc. Class A | 9.46 | +0.21% | $236.77M | vs NAGE |
| USNAUSANA Health Sciences Inc. | 14.67 | -1.08% | $271.05M | vs NAGE |
| BYNDBeyond Meat Inc. | 7.66 | -4.13% | $131.71M | vs NAGE |
| WYHGWing Yip Food Holdings Group Limited ADR | 3.63 | -4.47% | $129.16M | vs NAGE |
| LWAYLifeway Foods Inc. | 21.30 | +4.11% | $321.77M | vs NAGE |
| OTLYOatly Group AB ADR | 10.37 | -1.33% | $330.93M | vs NAGE |
Indexes, lists and sector
Largest Consumer Defensive stocks
Niagen Bioscience stock FAQ
What is Niagen Bioscience's stock price today?
NAGE last traded at $2.72 as of Oct 7, 4:00 PM EDT, up 1.12% on the day. Prices are delayed at least 15 minutes.
Does Niagen Bioscience pay a dividend?
No. Niagen Bioscience does not currently pay a regular cash dividend.
When is Niagen Bioscience's next earnings date?
Niagen Bioscience is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $0.00.
What is NAGE's P/E ratio?
NAGE trades at a trailing P/E ratio of 14.32 and a forward P/E of 27.20, compared with a median of 12.5 for its closest peers.
Who is Niagen Bioscience's CEO?
Mr. Robert N. Fried is the chief executive officer of Niagen Bioscience Inc., which has about 117 employees.
Has NAGE ever split its stock?
Yes. The most recent NAGE stock split was a 1-for-3 split on Apr 13, 2016.
What is the NAGE 52-week high?
The 52-week high for NAGE is $7.95 and the 52-week low is $2.61. The stock is currently 65.8% below its high.